San Diego, CA, May 9, 2019 – ACON Laboratories, Inc., a worldwide manufacturer of Point-of-care diagnostics, announced today the release of the On Call® Sure Platform in Europe and Latin America.
The On Call® Sure Platform was designed to meet the demands of professional testing. Its GDH-FAD enzyme offers the ability to test capillary, venous and arterial blood samples. The active correction of the system broadens its hematocrit range, making On Call Sure suitable for neonatal testing.
The On Call® Sure Strip Platform is compatible with two meters, On Call® Sure and On Call® Sure Sync (Bluetooth® integrated for wireless data transfer). Both meters offer a user friendly interface and a large easy to read display.
About ACON Laboratories, Inc. ACON Laboratories Inc. is a privately owned Diagnostics and Medical Device company, which was founded in 1996, with its headquarters located in San Diego, California. ACON Laboratories, Inc. produces a broad range of medical diagnostic and healthcare products that are sold in over 130 countries worldwide. The company continues to expand its product lines through extensive research and development, with the goal of helping improve the health and well-being of patients around the world. ACON’s manufacturing facility is a US FDA registered manufacturer of rapid diagnostic and healthcare products.
To learn more, please visit www.aconlabs.com or contact firstname.lastname@example.org.
Contact: Tiffany Oberman ACON Laboratories, Inc. (858) 875-8018 email@example.com